Thomas J Knightly, MD

EVOLVE demonstrated significant disorganization and lack of professionalism. Detailed medication information should have been requested before initiating treatment — especially for an intensive mental health therapy such as TMS. I was allowed to begin care, but after three sessions my treatment was paused until I provide additional information that will take time to obtain. When I expressed concern about the interruption — particularly because EVOLVE states the treatment must be done consecutively to be effective — I was advised that I could continue by paying out-of-pocket. This would have required a substantial financial commitment with no assurance that insurance would reimburse me. It has now been weeks, and I am still waiting to receive the medication information requested from my mail-order pharmacy. I am concerned about potential billing for the three sessions already completed if insurance denies EVOLVE’s claims due to the missing information. This situation has created… unnecessary stress and uncertainty. I spent considerable time researching TMS therapy and selecting a reputable provider, which makes this experience especially discouraging. This experience has undermined my confidence in a treatment that depends heavily on continuity of care and patient trust. Patients seeking TMS often have medication-resistant depression and are in a vulnerable position, making careful communication, coordination, and sensitivity especially important.